Clinical Trial Update: Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of combining irreversible electroporation (IRE) with γδ T cell therapy for locally advanced pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• IRE (irreversible electroporation) therapy
• T-cell therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED